1 STATEMENT OF THE ALLIANCE FOR PHARMACY COMPOUNDING: UNDERSTANDING LAW AND REGULATION GOVERNING THE COMPOUNDING OF PEPTIDE PROD The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 10mg High Purity, U.S. Made Research Peptides OROS Research Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Peptides for Pharmacies: How to Prepare for BPC 157, Category 1 Changes & What to Do Now (Webinar)